The Efficacy of Neuromodulation Interventions for Chemotherapy-Induced Peripheral Neuropathy: A Systematic Review and Meta-Analysis

References

• Burgess J, Ferdousi M, Gosal D, et al. Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment. Oncol Ther. 2021;9(2):385–450. doi:10.1007/s40487-021-00168-y
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Lacchetti C, Bleeker J, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update. J Clin Oncol. 2020;38(28):3325–3348. doi:10.1200/JCO.20.01399
   PubMed Web of Science ®Google Scholar
• Desforges AD, Hebert CM, Spence AL, et al. Treatment and diagnosis of chemotherapy-induced peripheral neuropathy: an update. Biomed Pharmacother. 2022;147:112671. doi:10.1016/j.biopha.2022.112671
   PubMed Web of Science ®Google Scholar
• Jordan B, Margulies A, Cardoso F, et al. Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO clinical practice guidelines for diagnosis, prevention, treatment and follow-up. Ann Oncol. 2020;31(10):1306–1319. doi:10.1016/j.annonc.2020.07.003
   PubMed Web of Science ®Google Scholar
• de Arenas-Arroyo S N, Cavero-Redondo I, Torres-Costoso A, Reina-Gutiérrez S, Lorenzo-García P, Martínez-Vizcaíno V. Effects of exercise interventions to reduce chemotherapy-induced peripheral neuropathy severity: a meta-analysis. Scand J Med Sci Sports. 2023;33(7):1040–53. doi:10.1111/sms.14360
   Web of Science ®Google Scholar
• Staff NP, Grisold A, Grisold W, Windebank AJ. Chemotherapy-induced peripheral neuropathy: a current review. Ann Neurol. 2017;81(6):772–781. doi:10.1002/ana.24951
   PubMed Web of Science ®Google Scholar
• Havrilesky LJ, Reiner M, Morrow PK, Watson H, Crawford J. A review of relative dose intensity and survival in patients with metastatic solid tumors. Crit Rev Oncol Hematol. 2015;93(3):203–210. doi:10.1016/j.critrevonc.2014.10.006
   PubMed Web of Science ®Google Scholar
• Miltenburg NC, Boogerd W. Chemotherapy-induced neuropathy: a comprehensive survey. Cancer Treat Rev. 2014;40(7):872–882. doi:10.1016/j.ctrv.2014.04.004
   PubMed Web of Science ®Google Scholar
• Flatters SJL, Dougherty PM, Colvin LA. Clinical and preclinical perspectives on chemotherapy-induced peripheral neuropathy (CIPN): a narrative review. Br J Anaesth. 2017;119(4):737–749. doi:10.1093/bja/aex229
   PubMed Web of Science ®Google Scholar
• Chow R, Novosel M, So OW, et al. Duloxetine for prevention and treatment of chemotherapy-induced peripheral neuropathy (CIPN): systematic review and meta-analysis. BMJ Support Palliat Care. 2023;13(1):27–34. doi:10.1136/spcare-2022-003815
   Web of Science ®Google Scholar
• Aghabozorgi R, Hesam M, Zahed G, Babaee M, Hashemi M, Rayegani SM. Efficacy of Duloxetine on electrodiagnostic findings of Paclitaxel-induced peripheral neuropathy, does it have a prophylactic effect? A randomized clinical trial. Anticancer Drugs. 2023;34(5):680. doi:10.1097/CAD.0000000000001429
   Web of Science ®Google Scholar
• Ashina M, Buse DC, Ashina H, et al. Migraine: integrated approaches to clinical management and emerging treatments. Lancet Lond Engl. 2021;397(10283):1505–1518. doi:10.1016/S0140-6736(20)32342-4
   PubMed Web of Science ®Google Scholar
• Knotkova H, Hamani C, Sivanesan E, et al. Neuromodulation for chronic pain. Lancet Lond Engl. 2021;397(10289):2111–2124. doi:10.1016/S0140-6736(21)00794-7
   PubMed Web of Science ®Google Scholar
• International neuromodulation society neuromodulation, or neuromodulatory effect; 2018. Avalable from: https://www.neuromodulation.com/neuromodulation-defined. Accessed March 28, 2024.
   Google Scholar
• Thompson T, Heathcote LC, Hobson H, Solmi M. Editorial: neuromodulatory Interventions for Pain. Front Neurosci. 2021;15:746328. doi:10.3389/fnins.2021.746328
   Web of Science ®Google Scholar
• Magee DJ, Schutzer-Weissmann J, Pereira EAC, Brown MRD. Neuromodulation techniques for cancer pain management. Curr Opin Support Palliat Care. 2021;15(2):77–83. doi:10.1097/SPC.0000000000000549
   Web of Science ®Google Scholar
• Zhi JF, Liao QH, He YB, Xu WW, Zhu DW, Shao LH. Superior treatment efficacy of neuromodulation rehabilitation for upper limb recovery after stroke: a meta-analysis. Expert Rev Neurother. 2022;22(10):875–888. doi:10.1080/14737175.2022.2137405
   PubMed Web of Science ®Google Scholar
• Wang M, Yin Y, Yang H, Pei Z, Molassiotis A. Evaluating the safety, feasibility, and efficacy of non-invasive neuromodulation techniques in chemotherapy-induced peripheral neuropathy: a systematic review. Eur J Oncol Nurs. 2022;58:102124. doi:10.1016/j.ejon.2022.102124
   Web of Science ®Google Scholar
• Wischnewski M, Alekseichuk I, Opitz A. Neurocognitive, physiological, and biophysical effects of transcranial alternating current stimulation. Trends Cognit Sci. 2023;27(2):189–205. doi:10.1016/j.tics.2022.11.013
   Web of Science ®Google Scholar
• D’Souza RS, Alvarez GAM, Dombovy-Johnson M, Eller J, Abd-Elsayed A. Evidence-based treatment of pain in chemotherapy-induced peripheral neuropathy. Curr Pain Headache Rep. 2023;27(5):99–116. doi:10.1007/s11916-023-01107-4
   Web of Science ®Google Scholar
• Albin B, Adhikari P, Tiwari AP, Qubbaj K, Yang IH. Electrical stimulation enhances mitochondrial trafficking as a neuroprotective mechanism against chemotherapy-induced peripheral neuropathy. iScience. 2024;27(3):109052. doi:10.1016/j.isci.2024.109052
   Web of Science ®Google Scholar
• Jin MY, Weaver TE, Farris A, Gupta M, Abd-Elsayed A. Neuromodulation for peripheral nerve regeneration: systematic review of mechanisms and in vivo highlights. Biomedicines. 2023;11(4):1145. doi:10.3390/biomedicines11041145
   Web of Science ®Google Scholar
• Omran M, Belcher EK, Mohile NA, et al. Review of the role of the brain in chemotherapy-induced peripheral neuropathy. Front Mol Biosci. 2021;8:693133. doi:10.3389/fmolb.2021.693133
   Web of Science ®Google Scholar
• Seidman AD, Piulson L, Vertosick E, et al. A phase IIA trial of acupuncture to reduce chemotherapy-induced peripheral neuropathy severity during neoadjuvant or adjuvant weekly paclitaxel chemotherapy in breast cancer patients. Eur J Cancer. 2018;101:12–19. doi:10.1016/j.ejca.2018.06.008
   Web of Science ®Google Scholar
• Smith TJ, Razzak AR, Blackford AL, et al. A pilot randomized sham-controlled trial of MC5-A scrambler therapy in the treatment of chronic chemotherapy-induced peripheral neuropathy (CIPN). J Palliat Care. 2020;35(1):53–58. doi:10.1177/0825859719827589
   Web of Science ®Google Scholar
• Molassiotis A, Suen LKP, Cheng HL, et al. A randomized assessor-blinded wait-list-controlled trial to assess the effectiveness of acupuncture in the management of chemotherapy-induced peripheral neuropathy. Integr Cancer Ther. 2019;18:153473541983650. doi:10.1177/1534735419836501
   Web of Science ®Google Scholar
• D’Souza RS, Her YF, Jin MY, Morsi M, Abd-Elsayed A. Neuromodulation therapy for chemotherapy-induced peripheral neuropathy: a systematic review. Biomedicines. 2022;10(8):1909. doi:10.3390/biomedicines10081909
   Web of Science ®Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. doi:10.1136/bmj.n71
   PubMed Web of Science ®Google Scholar
• Traeger AC, Gilbert SE, Harris IA, Maher CG. Spinal cord stimulation for low back pain. Cochrane Database Syst Rev. 2023;3(3):CD014789. doi:10.1002/14651858.CD014789.pub2
   Google Scholar
• Verville L, Hincapié CA, Southerst D, et al. Systematic Review to Inform a World Health Organization (WHO) clinical practice guideline: benefits and harms of transcutaneous electrical nerve Stimulation (TENS) for chronic primary low back pain in adults. J Occup Rehabil. 2023;33(4):651–660. doi:10.1007/s10926-023-10121-7
   Web of Science ®Google Scholar
• Huang JF, Zheng XQ, Chen D, et al. Can acupuncture improve chronic spinal pain? A systematic review and meta-analysis. Glob Spine J. 2021;11(8):1248–1265. doi:10.1177/2192568220962440
   Web of Science ®Google Scholar
• Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. doi:10.1136/bmj.l4898
   PubMed Web of Science ®Google Scholar
• Cochrane Handbook for systematic reviews of interventions, version 5.1.0; 2011. Cochrane Collaboration website. Available from: https://training.cochrane.org/handbook. Accessed March 28, 2024.
   Google Scholar
• Balshem H, Helfand M, Schünemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol. 2011;64(4):401–406. doi:10.1016/j.jclinepi.2010.07.015
   PubMed Web of Science ®Google Scholar
• Stringer J, Ryder WD, Mackereth PA, Misra V, Wardley AM. A randomised, pragmatic clinical trial of Acupuncture plus standard care versus standard care alone for Chemotherapy Induced peripheral Neuropathy (ACUFOCIN). Eur J Oncol Nurs. 2022;60:102171. doi:10.1016/j.ejon.2022.102171
   Web of Science ®Google Scholar
• Song SY, Park JH, Lee JS, et al. A randomized, placebo-controlled trial evaluating changes in peripheral neuropathy and quality of life by using low-frequency electrostimulation on breast cancer patients treated with chemotherapy. Integr Cancer Ther. 2020;19:1534735420925519. doi:10.1177/1534735420925519
   Web of Science ®Google Scholar
• Han X, Wang L, Shi H, et al. Acupuncture combined with methylcobalamin for the treatment of chemotherapy-induced peripheral neuropathy in patients with multiple myeloma. BMC Cancer. 2017;17(1):40. doi:10.1186/s12885-016-3037-z
   PubMedGoogle Scholar
• Lu W, Giobbie-Hurder A, Freedman RA, et al. Acupuncture for chemotherapy-induced peripheral neuropathy in breast cancer survivors: a randomized controlled pilot trial. Oncologist. 2020;25(4):310–318. doi:10.1634/theoncologist.2019-0489
   PubMed Web of Science ®Google Scholar
• D’Alessandro EG, Nebuloni Nagy DR, de Brito CMM, Almeida EPM, Battistella LR, Cecatto RB. Acupuncture for chemotherapy-induced peripheral neuropathy: a randomised controlled pilot study. BMJ Support Palliat Care. 2022;12(1):64–72. doi:10.1136/bmjspcare-2018-001542
   Web of Science ®Google Scholar
• Huang CC, Ho TJ, Ho HY, et al. Acupuncture relieved chemotherapy-induced peripheral neuropathy in patients with breast cancer: a pilot randomized sham-controlled trial. J Clin Med. 2021;10(16):3694. doi:10.3390/jcm10163694
   Web of Science ®Google Scholar
• Rostock M, Jaroslawski K, Guethlin C, Ludtke R, Schröder S, Bartsch HH. Chemotherapy-induced peripheral neuropathy in cancer patients: a four-arm randomized trial on the effectiveness of electroacupuncture. Evid Based Complement Alternat Med. 2013;2013:1–9. doi:10.1155/2013/349653
   Web of Science ®Google Scholar
• Iravani S, Kazemi Motlagh AH, Emami Razavi SZ, et al. Effectiveness of acupuncture treatment on chemotherapy-induced peripheral neuropathy: a pilot, randomized, assessor-blinded, controlled trial. Pain Res Manag. 2020;2020:1–11. doi:10.1155/2020/2504674
   Web of Science ®Google Scholar
• Tonezzer T, Caffaro LAM, Menon KRS, et al. Effects of transcutaneous electrical nerve stimulation on chemotherapy-induced peripheral neuropathy symptoms (CIPN): a preliminary case-control study. J Phys Ther Sci. 2017;29(4):685–692. doi:10.1589/jpts.29.685
   Google Scholar
• Teng C, Egger S, Blinman PL, Vardy JL. Evaluating laser photobiomodulation for chemotherapy-induced peripheral neuropathy: a randomised Phase II trial. Support Care Cancer. 2023;31(1):52. doi:10.1007/s00520-022-07463-y
   Web of Science ®Google Scholar
• Lindblad K, Bergkvist L, Johansson AC. Evaluation of the treatment of chronic chemotherapy-induced peripheral neuropathy using long-wave diathermy and interferential currents: a randomized controlled trial. Support Care Cancer. 2016;24(6):2523–2531. doi:10.1007/s00520-015-3060-7
   Web of Science ®Google Scholar
• Bao T, Baser R, Chen C, et al. Health-related quality of life in cancer survivors with chemotherapy-induced peripheral neuropathy: a randomized clinical trial. Oncologist. 2021;26(11):e2070–e2078. doi:10.1002/onco.13933
   Web of Science ®Google Scholar
• Rick O, von Hehn U, Mikus E, Dertinger H, Geiger G. Magnetic field therapy in patients with cytostatics-induced polyneuropathy: a prospective randomized placebo-controlled phase-III study: magnetic field therapy in chemotherapy-induced peripheral neuropathy. Bioelectromagnetics. 2017;38(2):85–94. doi:10.1002/bem.22005
   Web of Science ®Google Scholar
• Prinsloo S, Novy D, Driver L, et al. Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: a pilot study: neurofeedback for Neuropathy. Cancer. 2017;123(11):1989–1997. doi:10.1002/cncr.30649
   PubMed Web of Science ®Google Scholar
• Al Onazi MM, Yurick JL, Harris C, et al. Therapeutic ultrasound for chemotherapy-related pain and sensory disturbance in the hands and feet in patients with colorectal cancer: a pilot randomized controlled trial. J Pain Symptom Manage. 2021;61(6):1127–1138. doi:10.1016/j.jpainsymman.2020.10.028
   Web of Science ®Google Scholar
• Calhoun EA, Welshman EE, Chang CH, et al. Psychometric evaluation of the functional assessment of cancer therapy/gynecologic oncology group-neurotoxicity (Fact/GOG-Ntx) questionnaire for patients receiving systemic chemotherapy. Int J Gynecol Cancer off J Int Gynecol Cancer Soc. 2003;13(6):741–748. doi:10.1111/j.1525-1438.2003.13603.x
   PubMed Web of Science ®Google Scholar
• Postma TJ, Aaronson NK, Heimans JJ, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: the QLQ-CIPN20. Eur J Cancer Oxf Engl. 2005;41(8):1135–1139. doi:10.1016/j.ejca.2005.02.012
   PubMed Web of Science ®Google Scholar
• Musoro JZ, Sodergren SC, Coens C, et al. Minimally important differences for interpreting the EORTC QLQ-C30 in patients with advanced colorectal cancer treated with chemotherapy. Colorectal Dis. 2020;22(12):2278–2287. doi:10.1111/codi.15295
   Web of Science ®Google Scholar
• Luckett T, King MT, Butow PN, et al. Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations. Ann Oncol. 2011;22(10):2179–2190. doi:10.1093/annonc/mdq721
   PubMed Web of Science ®Google Scholar
• Cheng HL, Lopez V, Lam SC, et al. Psychometric testing of the functional assessment of cancer therapy/gynecologic oncology group—neurotoxicity (FACT/GOG-Ntx) subscale in a longitudinal study of cancer patients treated with chemotherapy. Health Qual Life Outcomes. 2020;18(1):246. doi:10.1186/s12955-020-01493-y
   Web of Science ®Google Scholar
• Farrar JT, Young JP, LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001;94(2):149–158. doi:10.1016/S0304-3959(01)00349-9
   PubMed Web of Science ®Google Scholar
• Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105–121. doi:10.1016/j.jpain.2007.09.005
   PubMed Web of Science ®Google Scholar
• Hesam‐Shariati N, Chang W, Wewege MA, et al. The analgesic effect of electroencephalographic neurofeedback for people with chronic pain: a systematic review and meta‐analysis. Eur J Neurol. 2022;29(3):921–936. doi:10.1111/ene.15189
   Web of Science ®Google Scholar
• Caro XJ, Winter EF. EEG biofeedback treatment improves certain attention and somatic symptoms in fibromyalgia: a pilot study. Appl Psychoph Biofeed. 2011;36(3):193–200. doi:10.1007/s10484-011-9159-9
   Web of Science ®Google Scholar
• Sharpe L, Ianiello M, Dear BF, Perry KN, Refshauge K, Nicholas MK. Is there a potential role for attention bias modification in pain patients? Results of 2 randomised, controlled trials. Pain. 2012;153(3):722–731. doi:10.1016/j.pain.2011.12.014
   PubMed Web of Science ®Google Scholar
• Kim M, Kim EM, Oh PS, et al. Usefulness of cyclic thermal therapy and red blood cell scintigraphy in patients with chemotherapy-induced peripheral neuropathy. Korean J Pain. 2021;34(4):427–436. doi:10.3344/kjp.2021.34.4.427
   Web of Science ®Google Scholar
• Hsieh YL, Fan YC, Yang CC. Low-level laser therapy alleviates mechanical and cold allodynia induced by oxaliplatin administration in rats. Support Care Cancer. 2016;24(1):233–242. doi:10.1007/s00520-015-2773-y
   Web of Science ®Google Scholar
• Caylor J, Reddy R, Yin S, et al. Spinal cord stimulation in chronic pain: evidence and theory for mechanisms of action. Bioelectron Med. 2019;5:12. doi:10.1186/s42234-019-0023-1
   PubMedGoogle Scholar
• He Y, Guo X, May BH, et al. Clinical evidence for association of acupuncture and acupressure with improved cancer pain: a systematic review and meta-analysis. JAMA Oncol. 2020;6(2):271. doi:10.1001/jamaoncol.2019.5233
   PubMed Web of Science ®Google Scholar
• Tella BA, Oghumu SN, Gbiri CAO. Efficacy of transcutaneous electrical nerve stimulation and interferential current on tactile acuity of individuals with nonspecific chronic low back pain. Neuromodulation Technol Neural Interface. 2022;25(8):1403–1409. doi:10.1111/ner.13522
   PubMed Web of Science ®Google Scholar
• Robijns J, Censabella S, Bulens P, Maes A, Mebis J. The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature. Lasers Med Sci. 2017;32(1):229–242. doi:10.1007/s10103-016-2056-y
   Web of Science ®Google Scholar
• Min YG, Baek HS, Lee KM, Hong YH. Differential response to scrambler therapy by neuropathic pain phenotypes. Sci Rep. 2021;11(1). doi:10.1038/s41598-021-89667-6
   Web of Science ®Google Scholar
• Zhao ZQ. Neural mechanism underlying acupuncture analgesia. Prog Neurobiol. 2008;85(4):355–375. doi:10.1016/j.pneurobio.2008.05.004
   PubMed Web of Science ®Google Scholar
• Uchida H, Nagai J, Ueda H. Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice. Mol Pain. 2014;10:71. doi:10.1186/1744-8069-10-71
   PubMed Web of Science ®Google Scholar
• Chen Y, Li D, Li N, et al. Role of nerve signal transduction and neuroimmune crosstalk in mediating the analgesic effects of acupuncture for neuropathic pain. Front Neurol. 2023;14:1093849. doi:10.3389/fneur.2023.1093849
   PubMed Web of Science ®Google Scholar
• Rossettini G, Campaci F, Bialosky J, Huysmans E, Vase L, Carlino E. The biology of placebo and nocebo effects on experimental and chronic pain: state of the art. J Clin Med. 2023;12(12):4113. doi:10.3390/jcm12124113
   Web of Science ®Google Scholar
• Atlas LY. How instructions, learning, and expectations shape pain and neurobiological responses. Annu Rev Neurosci. 2023;46:167–189. doi:10.1146/annurev-neuro-101822-122427
   Web of Science ®Google Scholar
• Colloca L. The placebo effect in pain therapies. Annu Rev Pharmacol Toxicol. 2019;59:191–211. doi:10.1146/annurev-pharmtox-010818-021542
   PubMed Web of Science ®Google Scholar
• Hohenschurz-Schmidt D, Draper-Rodi J, Vase L, et al. Blinding and sham control methods in trials of physical, psychological, and self-management interventions for pain (article I): a systematic review and description of methods. Pain. 2023;164(3):469–484. doi:10.1097/j.pain.0000000000002723
   Web of Science ®Google Scholar
• Prady SL, Burch J, Vanderbloemen L, Crouch S, MacPherson H. Measuring expectations of benefit from treatment in acupuncture trials: a systematic review. Complement Ther Med. 2015;23(2):185–199. doi:10.1016/j.ctim.2015.01.007
   Web of Science ®Google Scholar
• Jepma M, Koban L, van Doorn J, Jones M, Wager TD. Behavioural and neural evidence for self-reinforcing expectancy effects on pain. Nat Hum Behav. 2018;2(11):838–855. doi:10.1038/s41562-018-0455-8
   Web of Science ®Google Scholar
• Li X, Zhi L, Han KY, et al. Impact of baseline expectancy on outcome prediction of real and sham acupuncture for persistent chemotherapy-induced peripheral neuropathy pain in solid tumor survivors: a secondary analysis of a randomized clinical trial. Integr Cancer Ther. 2023;22:15347354221149992. doi:10.1177/15347354221149992
   Web of Science ®Google Scholar
• Krøigård T, Schrøder HD, Qvortrup C, et al. Characterization and diagnostic evaluation of chronic polyneuropathies induced by oxaliplatin and docetaxel comparing skin biopsy to quantitative sensory testing and nerve conduction studies. Eur J Neurol. 2014;21(4):623–629. doi:10.1111/ene.12353
   PubMed Web of Science ®Google Scholar
• Argyriou AA, Park SB, Islam B, et al. Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings. J Neurol Neurosurg Psychiatry. 2019;90(12):1361–1369. doi:10.1136/jnnp-2019-320969
   PubMed Web of Science ®Google Scholar
• McCrary JM, Goldstein D, Boyle F, et al. Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey. Support Care Cancer. 2017;25(11):3485–3493. doi:10.1007/s00520-017-3772-y
   PubMed Web of Science ®Google Scholar
• Hwang MS, Lee HY, Choi TY, et al. A systematic review and meta-analysis of the efficacy of acupuncture and electroacupuncture against chemotherapy-induced peripheral neuropathy. Medicine. 2020;99(17):e19837. doi:10.1097/MD.0000000000019837
   Web of Science ®Google Scholar
• Xu Z, Wang X, Wu Y, Wang C, Fang X. The effectiveness and safety of acupuncture for chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Front Neurol. 2022;13:963358. doi:10.3389/fneur.2022.963358
   Web of Science ®Google Scholar
• Pei LX, Yi Y, Guo J, et al. The effectiveness and safety of acupuncture/electroacupuncture for chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Acupunct Med. 2022:096452842210765. doi:10.1177/09645284221076512
   Web of Science ®Google Scholar
• Chien TJ, Liu CY, Fang CJ, Kuo CY. The efficacy of acupuncture in chemotherapy-induced peripheral neuropathy: systematic review and meta-analysis. Integr Cancer Ther. 2019;18:1534735419886662. doi:10.1177/1534735419886662
   Web of Science ®Google Scholar
• Wang C, Chen S, Jiang W. Treatment for chemotherapy-induced peripheral neuropathy: a systematic review of randomized control trials. Front Pharmacol. 2022;13:1080888. doi:10.3389/fphar.2022.1080888
   Web of Science ®Google Scholar
• Yang XY, Xia WY, Xu YY, et al. Patients’ expectancy scale of acupuncture: development and clinical performance test. Complement Ther Clin Pract. 2023;53:101797. doi:10.1016/j.ctcp.2023.101797
   Web of Science ®Google Scholar